Source:http://linkedlifedata.com/resource/pubmed/id/10688494
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-16
|
pubmed:abstractText |
Twenty-nine patients out of 2018 operated on for a non-small-cell lung cancer from 1987 to February 1998 met the criteria proposed by the Japan Lung Cancer Society (JLCS) for the definition of early hilar lung cancer (EHLC). Twenty-six patients were symptomatic and 20 had a radiologically visible lesion. All cancers were located and diagnosed by bronchoscopy and all patients were resected. At histology, all tumors were squamous in nature. The five-year cumulative survival rate was 96%--a second primary lung cancer (2nd Pr.) developed in 4 patients (13.8%). The definition of EHLC proposed by the JLCS allows the selection of a subgroup of stage I patients with a very good prognosis. Nevertheless, a close follow-up is mandatory because more than 10% of these patients develop a 2nd Pr.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0169-5002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-24
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10688494-Adult,
pubmed-meshheading:10688494-Aged,
pubmed-meshheading:10688494-Bronchoscopy,
pubmed-meshheading:10688494-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10688494-Carcinoma, Squamous Cell,
pubmed-meshheading:10688494-Carcinoma in Situ,
pubmed-meshheading:10688494-Female,
pubmed-meshheading:10688494-Humans,
pubmed-meshheading:10688494-Lung Neoplasms,
pubmed-meshheading:10688494-Male,
pubmed-meshheading:10688494-Middle Aged,
pubmed-meshheading:10688494-Neoplasm Staging,
pubmed-meshheading:10688494-Prognosis,
pubmed-meshheading:10688494-Survival Analysis
|
pubmed:year |
2000
|
pubmed:articleTitle |
Early hilar lung cancer--clinical aspects and long term survival. Identification of a subgroup of stage IA patients with more favorable prognosis.
|
pubmed:affiliation |
Divisione di Chirurgia Toracica, Ospedale Maggiore, Verona, Italy.
|
pubmed:publicationType |
Journal Article
|